Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/13553| Title: | The burden of respiratory disease |
| Authors: | Cordina, Maria |
| Keywords: | Editorials Respiratory organs -- Diseases Respiratory organs -- Treatment |
| Issue Date: | 2005 |
| Publisher: | Malta College of Pharmacy Practice |
| Citation: | Cordina, M. (2005). The burden of respiratory disease. The Chronic*ill, 9, 3-4. |
| Abstract: | Respiratory diseases are a leading cause of morbidity and mortality world wide. The World Health Organisation attributes 18.7% of the total number of deaths to respiratory disease, whilst in Europe respiratory diseases rank as the second cause of death after cardiovascular disease. In economic terms, respiratory diseases place a burden of approximately €102 billion on Europe. A total of €48.3 billion, being due to days lost from work with the leading cause (62.4%) being chronic obstructive pulmonary disease, followed by asthma (21.4%) and pneumonia (7.6%). In terms of pharmaceuticals, Europe spends €3.6 billion on anti-asthma drugs and €2.7 billion on drugs to treat COPD (European White Lung Book). |
| URI: | https://www.um.edu.mt/library/oar//handle/123456789/13553 |
| Appears in Collections: | JMCPP, Issue 9 JMCPP, Issue 9 |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Editorial.pdf | The burden of respiratory disease | 26.81 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.